Damian Heller

General Counsel at BASILEA PHARMACEUTICA AG

60 year

Consumer Services

Health Technology

Technology Services

Profile

Damian Heller is currently Secretary & General Counsel at Basilea Pharmaceutica AG since 2017.
Formerly, Mr. Heller was Director at Basel Institute on Governance from 2010 to 2013, Secretary at Syngenta AG from 2000 to 2007, and Global Compliance Officer at Novartis Pharma AG from 1996 to 2000.
Education includes an MBA from Rochester Christian University and graduate studies at the University of Basel.

Damian Heller active positions

Companies	Position	Start
BASILEA PHARMACEUTICA AG	General Counsel	2017-07-31

All active positions of Damian Heller

Former positions of Damian Heller

Companies	Position	End
Basel Institute on Governance	Director/Board Member	2012-12-31
SYNGENTA	Corporate Secretary	2007-03-31
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Compliance Officer	2000-09-30

See the detail of Damian Heller's experience

Training of Damian Heller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Damian Heller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Rochester Christian University Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syngenta AG Syngenta AG Packaged SoftwareTechnology Services Develops technologies and farming practices	Technology Services
Basilea Pharmaceutica AG Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
University of Basel University of Basel Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Basel Institute on Governance